ASPEN PHARUNADR (Germany) Top Insiders

LDZU Stock  EUR 8.55  0.05  0.59%   
Examination of ASPEN PHARUNADR's management performance can provide insight into the company performance.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ASPEN PHARUNADR 1. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Symbol  LDZU
Name  ASPEN PHARUNADR 1
TypeStock
Country  
 Germany
Exchange  F

Information on ASPEN PHARUNADR 1 Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

ASPEN PHARUNADR Management Team Effectiveness

The company has return on total asset (ROA) of 0.0499 % which means that it generated a profit of $0.0499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.095 %, meaning that it generated $0.095 on every $100 dollars invested by stockholders. ASPEN PHARUNADR's management efficiency ratios could be used to measure how well ASPEN PHARUNADR manages its routine affairs as well as how well it operates its assets and liabilities.

ASPEN PHARUNADR Workforce Comparison

ASPEN PHARUNADR 1 is currently regarded as number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 12,368. ASPEN PHARUNADR totals roughly 8,580 in number of employees claiming about 69% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

ASPEN PHARUNADR 1 Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ASPEN PHARUNADR 1 Price Series Summation is a cross summation of ASPEN PHARUNADR price series and its benchmark/peer.

About ASPEN PHARUNADR Management Performance

The success or failure of an entity such as ASPEN PHARUNADR 1 often depends on how effective the management is. ASPEN PHARUNADR management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ASPEN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ASPEN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. ASPEN PHAR is traded on Frankfurt Stock Exchange in Germany.

Complementary Tools for ASPEN Stock analysis

When running ASPEN PHARUNADR's price analysis, check to measure ASPEN PHARUNADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ASPEN PHARUNADR is operating at the current time. Most of ASPEN PHARUNADR's value examination focuses on studying past and present price action to predict the probability of ASPEN PHARUNADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ASPEN PHARUNADR's price. Additionally, you may evaluate how the addition of ASPEN PHARUNADR to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world